Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Pharmacal has taken over all rights of Bausch + Lomb's abbreviated new drug application (ANDA) for Nystatin Oral suspension.
Subscribe to our email newsletter
Hi-Tech is a pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products for the general healthcare industry,
Nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity.
Hi-Tech plans to introduce Nystatin oral suspension in all commercially available fill sizes as it meets all FDA requirements.